| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:PARP-2-IN-3
CAS:2915650-86-9
Purity:99% Package:1mg;5mg;25mg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:PARP-2-IN-3
CAS:2915650-86-9
Purity:99.08% Package:1mg/RMB 2350;5mg/RMB 7000;25mg/RMB 11200
|
PARP-2-IN-3 manufacturers
- PARP-2-IN-3
-
- $350.00 / 1mg
-
2025-05-19
- CAS:2915650-86-9
- Min. Order:
- Purity: 99.08%
- Supply Ability: 10g
|
| | PARP-2-IN-3 Basic information |
| | PARP-2-IN-3 Chemical Properties |
| Boiling point | 582.981±50.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.326±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 14.265±0.70(predicted) |
| | PARP-2-IN-3 Usage And Synthesis |
| Uses | PARP-2-IN-3 (Compound 12) is a potent PARP-2 inhibitor with an IC50 of 0.07 μM. PARP-2-IN-3 induces apoptosis and necrosis in cancer cells. PARP-2-IN-3 shows appropriate predicted pharmacokinetic parameters and oral bioavailability[1]. | | IC 50 | PARP-2: 0.07 μM (IC50) | | References | [1] El-Ghobashy NM, et al. Synthesis, biological evaluation, and molecular modeling studies of new benzoxazole derivatives as PARP-2 inhibitors targeting breast cancer. Sci Rep. 2022 Sep 28;12(1):16246. DOI:10.1038/s41598-022-20260-1 |
| | PARP-2-IN-3 Preparation Products And Raw materials |
|